-
-
-
-
-
-
-
Q32 Bio to release alopecia areata trial data on July 13
-
-
-
-
-
-
-
Q32 Bio (QTTB) Tops Q4 EPS by 458c
-
-
-
-
-
-
-
Q32 Bio (QTTB) Appoints Adrien Sipos as Interim Chief Medical Officer
-
-
-
-
-
-
-
Piper Sandler Downgrades Q32 Bio Inc. (QTTB) to Neutral
-
-
-
-
-
-
-
Raymond James Downgrades Q32 Bio Inc. (QTTB) to Outperform
-
-
-
-
-
-
-
Q32 Bio (QTTB) Misses Q2 EPS by 142c
-
-
435,246 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

